Completed
The Food and Drug Administration (FDA) defines regulatory science as the science of developing new tools, standards, and approaches to assess the safety, effectiveness, quality, toxicity, public health impact, or performance of FDA regulated products. This workshop provided a venue to review progress in building the foundations of regulatory science and explore a forward-looking agenda for bolstering the field. Participants examined the current state and scope of the discipline, highlight opportunities to address barriers to success, and explore ways to foster collaboration.
Please visit our event page for additional information and meeting materials for the workshop (held on October 20-21, 2015)
Featured publication
Workshop
ยท2016
The field of endeavors known as "regulatory science" has grown out of the need to link and integrate knowledge within and among basic science research, clinical research, clinical medicine, and other specific scientific disciplines whose focus, aggregation, and ultimate implementation could inform b...
View details
Description
An ad hoc committee will plan a one-day public workshop, to be convened as a collaboration between the Institute of Medicine and the Burroughs Wellcome Fund, that will discuss issues related to the development of the discipline of innovative regulatory science for medical product development, focusing on infrastructure, systems and workforce. The public workshop will feature invited presentations and discussions that will focus on: (1) the current scope and status of federal, academic, and private regulatory science strategic priorities; and (2) progress made in establishing workforce training and other infrastructure to advance the discipline of innovative regulatory science.
Subject matter experts will be invited to discuss key needs for further establishing and strengthening the discipline and to explore priorities and potential opportunities for collaboration to address those needs. The workshop will include consideration of the core components of the regulatory science infrastructure that include the workforce, process, and systems in the public and private sectors needed to foster innovation in medical product development and evaluation methodologies, with attention to the entire product development lifecycle.
The workshop will feature invited presentations and discussions that will:
- Explore current regulatory science priorities and strategies in federal, academic, and private sector settings.
- Consider the current state of regulatory science as a discipline.
- Discuss professional training successes.
- Highlight opportunities to further support training, workforce, and career development.
- Explore the core components of a robust discipline of innovative regulatory science.
- Consider gaps and key opportunities to address needs to support the discipline of innovative regulatory science.
- Examine needs and barriers to collaboration among, across, and within the public and private sectors.
The planning committee will develop the agenda for the workshop, select and invite speakers and discussants, and moderate or identify moderators for the discussions. A brief workshop summary will be prepared by a designated rapporteur based on the information gathered and discussions held during the workshop in accordance with institutional guidelines.
Contributors
Committee
Co-Chair
Co-Chair
Member
Member
Member
Member
Member
Member
Member
Member
Sponsors
Department of Health and Human Services
Private: For Profit
Private: Non Profit
Staff
Anne Claiborne
Lead
Carolyn Shore
Lead
Major units and sub-units
Health and Medicine Division
Lead
Institute of Medicine
Lead
Board on Health Sciences Policy
Lead
More like this
Events
Right Now & Next Up
Stay in the loop with canโt-miss sessions, live events, and activities happening over the next two days.
TRB Annual Meeting | January 11 - 15, 2026
January 11 - 15, 2026 | The TRB Annual Meeting brings together thousands of transportation professionals worldwide for sessions across all modes and sectors.